HomeStock ScreenerAdeshwar MeditexQuarterly Results

Adeshwar Meditex Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹2 Cr
QMarch 2025
Quarterly Results

In 2026, Adeshwar Meditex (ADESHWAR) reported revenue ₹30 Cr and net profit ₹1 Cr. For annual financials, live price and key ratios, visit ADESHWAR screener.

ADESHWAR Quarterly Results — Revenue, Profit & EPS Highlights

Adeshwar Meditex latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check Adeshwar Meditex market cap to track the company's total market size over time.

  • Revenue of ₹84 Cr in March 2025 (+0.0% vs March 2025, +5.0% vs March 2024)
  • Net Profit of ₹2 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹5 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 5.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹1.43 in March 2025 (+0.0% vs March 2025)

Adeshwar Meditex Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ADESHWAR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 30 84 80 83 65 -64.3% -
Net Profit (₹ Cr) 1 2 2 2 1 - -
EBITDA (₹ Cr) 3 5 5 6 4 - -
EPS (₹) 1.30 1.43 1.43 1.44 0.55 - -
Operating Margin (%) 5.0% 5.0% 6.0% 6.0% 5.0% - -

ADESHWAR Share Price Trend — 1-Year Movement Across Quarterly Results

Adeshwar Meditex 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse ADESHWAR shareholding pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 2.4%
EBITDA Margin 6.0%
Operating Margin 5.0%
ROE (Annual) 5.4%

Balance Sheet Highlights

Total Assets ₹72 Cr
Total Equity ₹37 Cr
Current Assets ₹67 Cr
Current Liabilities ₹2 Cr

Cash Flow Analysis

Operating Cash Flow ₹4 Cr
Investing Cash Flow ₹1 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹2 Cr

ADESHWAR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Adeshwar Meditex latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026
₹463,071.60 Cr 1902.4 15,018 2,710 -5.6% - 18.0% 168.4
Divis Laboratories
Mar 2026
₹225,157.18 Cr 8597.0 2,986 751 -5.0% - 25.2% 303.7
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4896.5 4,111 364 +27.7% +42.2% 8.9% 425.4
Cipla
Mar 2026
₹115,699.61 Cr 1432.2 6,612 543 -9.3% - 8.2% 208.5
Zydus Life Science
Mar 2026
₹113,855.38 Cr 1120.0 7,569 1,341 -4.3% - 17.7% 88.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores